Royalty Pharma: Citigroup raises target price to $78 from $70
RPRX•Citigroup raised its target price on Royalty Pharma to $78 from $70.
Related News
HCI Group target price raised to $245 from $235
HCI•
Luckin Coffee publishes Q3 2026 earnings call transcript
LKNCY•
Gibraltar Industries names Jeffrey Watorek interim CFO, effective Nov. 20, 2026
ROCK•
Franklin Covey: Northland Capital cuts target price to $27 from $38
FC•
Truist Securities raises Five Below target price to $302 from $297
FIVE•